| Overall |  | Male |  | Female | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
β | SE | 95% CI* |  | β | SE | 95% CI* |  | β | SE | 95% CI* | |
Internalizing problems as mediator 2 | Â | Â | Â | Â | Â | Â | Â | Â | |||
Total Effect | 0.113 | 0.024 | 0.067 to 0.159 | Â | 0.124 | 0.031 | 0.064 to 0.185 | Â | 0.094 | 0.036 | 0.024 to 0.164 |
Direct Effect | 0.095 | 0.023 | 0.050 to 0.140 | Â | 0.100 | 0.030 | 0.040 to 0.159 | Â | 0.080 | 0.034 | 0.013 to 0.146 |
Total Indirect Effect | 0.018 | 0.009 | 0.0003 to 0.036 | Â | 0.025 | 0.012 | 0.002 to 0.049 | Â | 0.015 | 0.015 | -0.015 to 0.043 |
Indirect pathways | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CM→ SE → DS | 0.009 | 0.004 | 0.001 to 0.018 |  | 0.017 | 0.007 | 0.004 to 0.033 |  | 0.004 | 0.005 | -0.006 to 0.015 |
CM →IP → DS | 0.006 | 0.008 | −0.010 to 0.022 |  | 0.004 | 0.009 | -0.013 to 0.022 |  | 0.009 | 0.014 | -0.020 to 0.035 |
CM → SE →IP → DS | 0.003 | 0.001 | 0.001 to 0.006 |  | 0.004 | 0.002 | 0.001 to 0.008 |  | 0.014 | 0.002 | -0.002 to 0.005 |
Externalizing problems as mediator 2 | Â | Â | Â | Â | Â | Â | Â | Â | |||
Total Effect | 0.108 | 0.024 | 0.061 to 0.154 | Â | 0.120 | 0.032 | 0.058 to 0.183 | Â | 0.086 | 0.036 | 0.015 to 0.156 |
Direct Effect | 0.078 | 0.023 | 0.032 to 0.124 | Â | 0.084 | 0.031 | 0.023 to 0.146 | Â | 0.054 | 0.035 | -0.015 to 0.123 |
Total Indirect Effect | 0.030 | 0.008 | 0.014 to 0.046 | Â | 0.036 | 0.012 | 0.014 to 0.061 | Â | 0.032 | 0.012 | 0.008 to 0.056 |
Indirect pathways | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CM → SE→ DS | 0.012 | 0.004 | 0.004 to 0.021 |  | 0.022 | 0.008 | 0.008 to 0.040 |  | 0.005 | 0.005 | -0.005 to 0.016 |
CM → EP → DS | 0.018 | 0.007 | 0.005 to 0.032 |  | 0.014 | 0.009 | -0.003 to 0.033 |  | 0.027 | 0.012 | 0.005 to 0.050 |
CM → SE →EP → DS | 0.000 | 0.001 | −0.002 to 0.002 |  | -0.0002 | 0.001 | -0.003 to 0.003 |  | 0.000 | 0.001 | -0.003 to 0.003 |